Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility and outcomes in muscle invasive bladder cancer patients

European Journal of Cancer

Volumn 49, Issue 14, 2013, Pages 3010-3019

  Kang, Ho Won ^a   Song, Phil Hyun ^b   Ha, Yun Sok ^a,e   Kim, Won Tae ^a   Kim, Yong June ^a   Yun, Seok Joong ^a   Lee, Sang Cheol ^a   Choi, Yung Hyun ^c   Moon, Sung Kwon ^d   Kim, Wun Jae ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c Dong Eui University   (South Korea)

^d Chungju National University   (South Korea)

^e ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Bladder cancer; Epidemiology; Glutathione; GSTT1; Polymorphism; Prognosis; S transferase

Indexed keywords

CISPLATIN; GENOMIC DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; MULTIPLEX POLYMERASE CHAIN REACTION; MUSCLE INVASIVE BLADDER CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SMOKING; TREATMENT OUTCOME;

BLADDER CANCER; EPIDEMIOLOGY; GLUTATHIONE S-TRANSFERASE; GSTT1; POLYMORPHISM; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLES; NEOPLASM INVASIVENESS; POLYMORPHISM, GENETIC; PROGNOSIS; SMOKING; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84883051260     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.05.019     Document Type: Article

References (33)

1. R. Pilchowski, R. Stohr, and F. von Eggeling Specific protein patterns characterize metastatic potential of advanced bladder cancer J Urol 186 2011 713
2. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10
3. M.G. Bol, J.P. Baak, and S. Buhr-Wildhagen Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder J Urol 169 2003 1291
4. W.M. Murphy, K. Takezawa, and N.A. Maruniak Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care J Urol 168 2002 968
5. T. Habuchi, M. Marberger, and M.J. Droller Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers Urology 66 2005 64
6. W.J. Kim, E.J. Kim, and S.K. Kim Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer Mol Cancer 9 2012 3
7. T.R. Rebbeck Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility Cancer Epidemiol Biomarkers Prev 6 1997 733
8. Z. Jiang, C. Li, and X. Wang Glutathione S-transferase M1 polymorphism and bladder cancer risk: a meta-analysis involving 33 studies Exp Biol Med (Maywood) 236 2011 723
9. L.S. Engel, E. Taioli, and R. Pfeiffer Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review Am J Epidemiol 156 2002 95
10. M. McGrath, D. Michaud, and I. De Vivo Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women BMC Cancer 6 2006 239
11. G.I. Mossallam, T.M. Abdel Hamid, and M.A. Samra Glutathione S-transferase GSTM1 and GSTT1 polymorphisms in adult acute myeloid leukemia; its impact on toxicity and response to chemotherapy J Egypt Natl Canc Inst 18 2006 264
12. C.B. Ambrosone, C. Sweeney, and B.F. Coles Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer Cancer Res 61 2001 7130
13. S.M. Davies, L.L. Robison, and J.D. Buckley Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia J Clin Oncol 19 2001 1279
14. C. Sweeney, V. Nazar-Stewart, and P.L. Stapleton Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients Cancer Epidemiol Biomarkers Prev 12 2003 527
15. Z. Wang, W. He, and G. Yang Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma BMC Cancer 10 2010 352
16. Y.S. Ha, C. Yan, and M.S. Lym GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer Dis Markers 29 2010 81
17. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder Eur Urol 54 2008 303
18. F.L. Greene The American Joint Committee on Cancer: updating the strategies in cancer staging Bull Am Coll Surg 87 2002 13
19. H. Chen, D.P. Sandler, and J.A. Taylor Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect Lancet 347 1996 295
20. Y. Hirao, W.J. Kim, and K. Fujimoto Environmental factors promoting bladder cancer Curr Opin Urol 19 2009 494
21. A.S. Salinas-Sánchez, F. Sanchez-Sanchez, and M.J. Donate-Moreno Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer BJU Int 107 2011 1825
22. J.D. Hayes, and D.J. Pulford The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit Rev Biochem Mol Biol 30 1995 445
23. A. DeMichele, R. Aplenc, and J. Botbyl Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort J Clin Oncol 23 2005 5552
24. G. Yang, X.O. Shu, and Z.X. Ruan Genetic polymorphisms in glutathione-S-transferase genes (GSTM1, GSTT1, GSTP1) and survival after chemotherapy for invasive breast carcinoma Cancer 103 2005 52
25. C.H. Bosken, Q. Wei, and C.I. Amos An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer J Natl Cancer Inst 94 2002 1091
26. K.A. Olaussen, A. Dunant, and P. Fouret DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983
27. W. Zhou, S. Gurubhagavatula, and G. Liu Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy Clin Cancer Res 10 2004 4939
28. C. Tibaldi, E. Giovannetti, and E. Vasile Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients Clin Cancer Res 14 2008 1797
29. X. Wu, C. Lu, and Y. Ye Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy Pharmacogenet Genomics 18 2008 955
30. S.B. Saxman, K.J. Propert, and L.H. Einhorn Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 15 1997 2564
31. H. von der Maase, L. Sengelov, and J.T. Roberts Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer J Clin Oncol 23 2005 4602
32. H.H. Nelson, J.K. Wiencke, and D.C. Christiani Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta Carcinogenesis 16 1995 1243
33. D.D. Kwon, J.W. Lee, and D.Y. Han Relationship between the glutathione-S-transferase P1, M1, and T1 genotypes and prostate cancer risk in Korean subjects Korean J Urol 52 2011 247